Unravel Biosciences, Inc.
Clinical trials sponsored by Unravel Biosciences, Inc., explained in plain language.
-
Could a cancer drug help kids with rare pitt hopkins syndrome?
Disease control Recruiting nowThis early study tests the safety and effects of vorinostat, a drug currently used for cancer, in 5 people with Pitt Hopkins syndrome (ages 3-21). Each person will try a placebo and two different doses of the drug to see if it helps with symptoms and is safe. The goal is to gathe…
Phase: PHASE1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 05:24 UTC
-
New hope for rett syndrome: vorinostat trial launches
Disease control Recruiting nowThis early-stage study tests the safety and effectiveness of vorinostat in 15 girls and young women (ages 6-21) with Rett syndrome. Each participant acts as their own control, receiving placebo first, then two different doses of the drug. The goal is to see if vorinostat can impr…
Phase: PHASE1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC